Australia
· Delayed Price · Currency is AUD Recce Pharmaceuticals Statistics
Total Valuation
ASX:RCE has a market cap or net worth of AUD 72.42 million. The enterprise value is 75.22 million.
| Market Cap | 72.42M |
| Enterprise Value | 75.22M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:RCE has 249.73 million shares outstanding. The number of shares has increased by 7.17% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 249.73M |
| Shares Change (YoY) | +7.17% |
| Shares Change (QoQ) | +30.98% |
| Owned by Insiders (%) | 26.17% |
| Owned by Institutions (%) | 12.77% |
| Float | 169.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.55 |
| PB Ratio | -14.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.19 |
| EV / Sales | 7.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.58 |
Financial Position
The company has a current ratio of 0.36
| Current Ratio | 0.36 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.35 |
| Interest Coverage | -12.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -217.58% |
| Return on Invested Capital (ROIC) | -774.31% |
| Return on Capital Employed (ROCE) | 402.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.98 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.72% in the last 52 weeks. The beta is 0.96, so ASX:RCE's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -56.72% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 34.01 |
| Average Volume (20 Days) | 247,956 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:RCE had revenue of AUD 9.59 million and -17.94 million in losses. Loss per share was -0.09.
| Revenue | 9.59M |
| Gross Profit | -1.22M |
| Operating Income | -16.85M |
| Pretax Income | -17.94M |
| Net Income | -17.94M |
| EBITDA | -16.78M |
| EBIT | -16.85M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 1.94 million in cash and 4.74 million in debt, giving a net cash position of -2.80 million or -0.01 per share.
| Cash & Cash Equivalents | 1.94M |
| Total Debt | 4.74M |
| Net Cash | -2.80M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -4.99M |
| Book Value Per Share | -0.02 |
| Working Capital | -5.39M |
Cash Flow
In the last 12 months, operating cash flow was -13.42 million and capital expenditures -53,572, giving a free cash flow of -13.47 million.
| Operating Cash Flow | -13.42M |
| Capital Expenditures | -53,572 |
| Free Cash Flow | -13.47M |
| FCF Per Share | -0.05 |
Margins
Gross margin is -12.69%, with operating and profit margins of -175.65% and -186.95%.
| Gross Margin | -12.69% |
| Operating Margin | -175.65% |
| Pretax Margin | -186.95% |
| Profit Margin | -186.95% |
| EBITDA Margin | -174.91% |
| EBIT Margin | -175.65% |
| FCF Margin | n/a |
Dividends & Yields
ASX:RCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.17% |
| Shareholder Yield | -7.17% |
| Earnings Yield | -24.76% |
| FCF Yield | -18.60% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:RCE has an Altman Z-Score of -31.2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -31.2 |
| Piotroski F-Score | n/a |